Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Jayasree K. Iyer joins panel discussion at HLTH Europe 2025

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, has been invited to speak at the HLTH Europe 2025 event. As a panelist, she will present key insights on inclusive clinical trials, equitable health products, and access challenges in marginalised communities in low- and middle-income countries (LMICs).

Date

17 June 2025

Location

Amsterdam, Netherlands

HLTH Europe is an annual event held in Amsterdam that brings together leaders from industry, government, and the investment community. Designed to spark innovation, foster collaboration, and break down barriers, the event aims to inspire dialogue and drive progress toward a stronger, more inclusive healthcare system. 

One of the key sessions this year, “The inclusion paradox: Why inclusion is often excluded,” will explore how embedding equity from the outset can transform healthcare systems. The discussion will focus on integrating the needs of underserved populations at every stage, from research and development to access and delivery. As CEO of the Access to Medicine Foundation, Jayasree K. Iyer has been invited to participate in this session as a key panelist. She will present insights on inclusive clinical trials, equitable health products, and access challenges in marginalised communities in LMICs, drawn from the 2024 Access to Medicine Index. During the session, she will speak alongside: 

  • Richard Stubbs, CEO, Health Innovation Yorkshire & Humber 

  • John Chinegwundoh, Trust Lead for Health Equity, Physician, Kingston & Richmond NHS Foundation Trust 

About HLTH Europe 

Building on the success of its inaugural 2024 event, HLTH Europe 2025 will bring together over 5,000 leaders and innovators from across the European healthcare landscape. This year’s event will serve as a platform where global expertise meets local insight to tackle Europe and the world’s most pressing healthcare challenges and seize emerging opportunities. 

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Resource Centre

Read the key findings from 2024 Access to Medicine Index Key findings
Key findings

Pharma companies are taking steps to address access in low-income countries, but significant gaps remain

19 November 2024
Key findings

Patients in low- and middle-income countries largely left out of clinical trials, limiting access to new treatments

19 November 2024
Key findings

Efforts to ramp up wider local availability of medicines through voluntary licensing and technology transfers are limited

19 November 2024

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved